News

SAN DIEGO, CA – MARCH 10, 2022 – Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of precision medicine in psoriasis,  has appointed Ted St. Martin as its Chief Financial Officer (CFO), effective March 7, 2022. Mr. St. Martin brings over 25 years of experience in technical accounting and

Mr. Decker has 30+ years operating and finance experience in Fortune 500, middle market and emerging growth companies as both a full-time employee and as a fractional CFO. His broad experience includes technology, software, life sciences and healthcare. He has functional expertise in financing, operations, intellectual property licensing, strategic planning, contracts, supply and demand planning,

MENLO PARK, Calif.— March 2, 2022 — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that data from clinical studies of the OMNI® Surgical System will be presented at the 2022 American Glaucoma Society (AGS) Annual Meeting. The conference

Ms. Rice-Johnson has more than 30 years of experience in the health insurance industry and is CEO of Diversified Businesses for Highmark Inc. and chief growth officer. Her leadership has not only redefined the payer-provider relationship and yielded unparalleled financial performance, but she has also delivered innovative clinical solutions that aim to improve health outcomes. Her

SAN DIEGO, CA – March 1, 2022 – Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis,   has appointed Deborah L. Rice-Johnson to its Board of Directors, effective February 28, 2022.  Ms. Rice-Johnson has more than 30 years of experience in the health insurance industry.

MENLO PARK, Calif.— February 17, 2022 — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced the launch of its “Don’t Wait for Too Late” educational campaign designed to raise awareness among the optometric community of minimally invasive

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the close of a $26 million Series B financing. The round was led by 3×5 Partners, along with new investors including Asahi Kasei Ventures, Cadence Healthcare Ventures, and existing investors Arboretum

2021 Brought Breakthrough Device Designation and PMA Process Initiation San Carlos, Calif. (February 1, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, achieved several clinical, reimbursement and regulatory

Berkeley, California January. 25, 2022  Channel Medsystems, Inc. a medical device company dedicated to bringing innovation to the delivery of women’s healthcare, today announced that Lisa Garrett has joined the company’s Board of Directors. “Lisa brings a wealth of financial leadership experience at large and emerging companies in the healthcare industry,” said Ric Cote, Chief Executive

Partnership to focus on improving patient outcomes while reducing healthcare system costs of expensive biologic therapeutics SAN DIEGO, CA and LAKELAND, FL – January 4, 2022 – Mindera Health™ and WellDyne have entered into a definitive agreement to improve the management of psoriasis patients with moderate to severe disease using a proprietary dermal biomarker patch